Clinical Pharmacy Basics Certificate
Release Date: June 5, 2024 Expiration Date: June 5, 2027 ACPE Numbers: Various – see below |
Overview
The Clinical Pharmacy Basics Certificate is self-guided, with online learning modules that are designed to teach fundamental concepts of patient-centered clinical skills for pharmacists. The curriculum will cover core principles of clinical pharmacy practice and patient care roles of pharmacists. The course will present pharmacist-led activities in key clinical areas. After completing all of the modules, participants will have the foundational knowledge necessary to provide clinical pharmacy services in their practice settings.
Clinical Pharmacy Basics Certificate Requirement
Once a learner has completed the educational curriculum, they will have the opportunity to complete an online comprehensive exam. Once the learner completes the exam (minimum 80% passing rate; unlimited attempts permitted), they will earn the professional certificate.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
This self-paced, online professional certificate is intended for pharmacists who are interested in gaining the foundational knowledge necessary to provide clinical pharmacy services in their practice settings. Participants will be assumed to have the required pharmacy content knowledge but not necessarily the education-related knowledge and skills included in this certificate.
Course Modules
Learning Activity |
ACPE Number |
Contact Hours |
Orientation to Clinical Pharmacy Practice, Pharmacists as Caregivers, and Transitions of Care |
0204-0000-24-771-H04-P |
3.5 |
Evidence-based Medicine and Drug Information |
0204-0000-24-772-H04-P |
2.0 |
Renal Pharmacotherapy and Fluids and Electrolytes |
0204-0000-24-773-H01-P |
2.5 |
Pharmacokinetics, Nutrition, and Critical Care |
0204-0000-24-774-H01-P |
3.0 |
Diabetes, Cardiovascular, and Dermatologic Pharmacotherapy |
0204-0000-24-775-H01-P |
3.0 |
Special Populations and Infectious Diseases |
0204-0000-24-776-H01-P |
2.25 |
Pulmonary Disorders |
0204-0000-24-777-H01-P |
2.25 |
Gastrointestinal Disorders and Coping with Chemotherapy |
0204-0000-24-778-H01-P |
1.75 |
Neurological Disorders, Pain Management, and Rheumatology |
0204-0000-24-779-H01-P |
3.25 |
→ Final Assessment: (80% passing score required) |
Learning Objectives
Orientation to Clinical Pharmacy Practice, Pharmacists as Caregivers, and Transitions of Care
ACPE: 0204-0000-24-771-H04-P
CE Hours: 3.5 contact hours
Activity Type: Knowledge-based
- Summarize the history, evolution, and advancement of clinical pharmacy practice.
- Describe the standards of practice for a hospital clinical pharmacist in the United States of America.
- Discuss how ambulatory care pharmacists address the provision of integrated, accessible healthcare services for ambulatory patients in a wide variety of settings, including community pharmacies, clinic, and physician offices.
- Identify the importance of supporting futuristic practice models that support the most effective use of pharmacists as direct patient care providers.
- Describe the role of the clinical pharmacist on the patient care team.
- Discuss information obtained from the patient medical record used to develop drug therapy recommendations.
- Identify drug information resources available to assist clinical pharmacists.
- Describe strategies to monitor and document patient response to pharmacotherapy interventions using a patient medical record.
- Describe the role of the pharmacist in care transitions between multiple settings.
- Explain the steps to complete a medication history and medication reconciliation.
- Describe evidence supporting the role of pharmacists in admission and discharge medication reconciliation.
Evidence-based Medicine and Drug Information
ACPE: 0204-0000-24-772-H04-P
CE Hours: 2 contact hours
Activity Type: Application-based
- Describe the elements of evidence-based medicine.
- Evaluate study design for appropriateness and limitations.
- Assess clinical practice guidelines for validity and applicability.
- Solve biostatistics calculations.
- Describe the role of the pharmacist in providing drug information.
- Differentiate between primary, secondary, and tertiary sources of information.
Renal Pharmacotherapy and Fluids and Electrolytes
ACPE: 0204-0000-24-773-H01-P
CE Hours: 2.5 contact hours
Activity Type: Application-based
- Describe the role of key components of the nephron.
- Explain how glomerular filtration, active secretion, and passive reabsorption contribute to renal clearance.
- Select the medication dose using the Cockcroft-Gault equation.
- Describe the distribution of total body fluid and expected distribution of various intravenous fluids.
- Compare examples of a hypotonic fluid, isotonic fluid, and hypertonic fluid.
- Recommend pharmacotherapy interventions based on patient criteria and electrolyte abnormalities.
Pharmacokinetics, Nutrition, and Critical Care
ACPE: 0204-0000-24-774-H01-P
CE Hours: 3 contact hours
Activity Type: Application-based
- Describe clinical pharmacodynamics as it relates to medication dosing.
- Describe the role of pharmacokinetics in therapeutic drug monitoring for vancomycin and aminoglycosides.
- Differentiate between pharmacokinetics and pharmacodynamics.
- Describe nutritional requirements.
- Compare and contrast enteral and parenteral nutrition in hospitalized patients.
- Identify the signs and symptoms of refeeding syndrome.
- Describe common medication-related challenges in critically ill patients.
- Identify drug-related problems in the intensive care unit.
- Apply guideline-based interventions in patients with sepsis.
- Contrast treatment approaches for analgesia and sedation in critically ill patients.
- Assess how to treat and prevent delirium in the intensive care unit.
Diabetes, Cardiovascular, and Dermatologic Pharmacotherapy
ACPE: 0204-0000-24-775-H01-P
CE Hours: 3 contact hours
Activity Type: Application-based
- Differentiate between type 1 and type 2 diabetes.
- Identify different classes of medications used to treat diabetes.
- Explain how to reduce and treat hypoglycemia.
- Define diabetic ketoacidosis and hyperosmolar hyperglycemic state.
- Recommend first-line medication treatments for diabetic ketoacidosis and hyperosmolar hyperglycemic state.
- Identify medications used to treat hypertension and dyslipidemia.
- List first-line medications that are used in Acute Coronary Syndromes (ACS), Cerebrovascular Accident (CVA), and Transient Ischemic Attack (TIA).
- Describe rate vs. rhythm control strategies.
- Differentiate anticoagulants used in Atrial Fibrillation (AFib).
- Summarize appropriate pharmacological treatment of acute/chronic heart failure.
- Describe the pathology of common skin disorders.
- Identify medications for common skin disorders.
- Counsel patients about dermatologic skin products.
- Select appropriate skin care products based on patient symptoms.
Special Populations and Infectious Diseases
ACPE: 0204-0000-24-776-H01-P
CE Hours: 2.25 contact hours
Activity Type: Application-based
- Differentiate the pharmacokinetics in geriatric and pediatric populations.
- List medications on the BEERs criteria.
- Recommend appropriate dosing for pediatric patients.
- Identify pregnancy and lactation drug references and resources.
- Describe the role a hospital clinical pharmacist plays in the management of common infectious diseases.
- Recommend antimicrobial medications and protocols.
- Identify elements of a hospital antimicrobial stewardship program.
- Understand how to read a culture and sensitivity report.
Pulmonary Disorders
ACPE: 0204-0000-24-777-H01-P
CE Hours: 2.25 contact hours
Activity Type: Application-based
- Given a patient case, assess the severity and level of control of their asthma.
- Recommend appropriate pharmacotherapy for patients with asthma.
- Identify medication safety and tolerability concerns for patients with asthma.
- Given a patient case, assess the severity and level of control of their chronic obstructive pulmonary disease.
- Identify medication safety and tolerability concerns.
- Recommend appropriate pharmacotherapy for patients with chronic obstructive pulmonary disease.
Gastrointestinal Disorders and Coping with Chemotherapy
ACPE: 0204-0000-24-778-H01-P
CE Hours: 1.75 contact hours
Activity Type: Application-based
- Identify medications that can cause constipation, diarrhea, and nausea and vomiting.
- List medications used to treat constipation, diarrhea, and nausea and vomiting.
- Differentiate between pharmacologic classes of medications used to treat gastroesophageal reflux disease.
- Summarize medications used in inflammatory bowel disease, including potential adverse effects.
- Recommend an appropriate treatment plan for a patient with a gastrointestinal bleed.
- Assess the risk of chemotherapy-induced nausea and vomiting based on emetogenic potential and patient risk factors.
- Apply guideline-based recommendations for management of chemotherapy side effects.
- Summarize the rationale for side effect management in clinical cases.
Neurological Disorders, Pain Management, and Rheumatology
ACPE: 0204-0000-24-779-H01-P
CE Hours: 3.25 contact hours
Activity Type: Application-based
- Describe management of acute stroke.
- Differentiate the role of a clinical pharmacist in the management of mental health disorders and pain.
- Compare common analgesics used in the treatment of pain.
- Discuss the main causes for gout.
- List the most common treatments for gout.
- Recommend a medication treatment plan for a patient with gout.
- Develop a treatment plan for a patient unable to take oral medications.
- Discuss the main causes for osteoarthritis.
- List the most common treatments for osteoarthritis.
- Recommend a medication treatment plan for a patient with osteoarthritis.
- Discuss the main causes for rheumatoid arthritis.
- List the most common treatments for rheumatoid arthritis.
- Recommend a medication treatment plan for a patient with rheumatoid arthritis.
Faculty
Joshua Bayer, PharmD, BCPS, AAHIVP
Clinical Pharmacy Specialist
Department of Veterans Affairs
La Crosse, Wisconsin
Suzanne Bollmeier, PharmD, FCCP, BCPS, AE-C
Professor, Pharmacy Practice
St. Louis College of Pharmacy at UHSP
St. Louis, Missouri
Paul M. Boylan, PharmD, BCPS
Assistant Professor
The University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma
Daniel Brust, PharmD
Clinical Pharmacist Practitioner
Wilkes-Barre Veterans Affairs Medical Center
Wilkes-Barre, Pennsylvania
Michelle Marie Estevez, PharmD, RPh, CPh, BCPS, DPLA
Pharmacy Manager
Lee Health
Estero, Florida
Seth Garner, PharmD, BCCCP
Trauma ICU Pharmacist
Atrium Health Wake Forest Baptist Medical Center
Winston Salem, North Carolina
Amanda L. Hedrick, PharmD
Critical Care Clinical Pharmacist
UVA Health
Charlottesville, Virginia
J. Nate Hedrick, PharmD
Clinical Pharmacist - Emergency Department
UVA Health
Charlottesville, Virginia
Mary J. Ketchner, PharmD
Clinical Pharmacist
Walter Reed National Military Medical Center
Bethesda, Maryland
Thomas J. Pierson, PharmD
Pharmacy Manager of Specialty Clinic Services
Cleveland Clinic
Cleveland, Ohio
Kate Taucher, PharmD, MHA, BCOP
Ambulatory Oncology Clinical Pharmacy Specialist
PGY2 Oncology Residency Program Director
UCHealth Memorial Hospital
Medical Key Account Manager
G1 Therapeutics
Colorado Springs, Colorado
Jason T. Wong, PharmD, MBA, CPPS, DPLA
Director of Pharmacy
UCSF Health
San Francisco, California
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of activity content have relevant financial relationships:
- Kate Taucher: GI Therapeutics, employee
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
Methods and CE Requirements
Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP profile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.
The ASHP PROFESSIONAL CERTIFICATES℠ educational product line contains learning activities that are ACPE-accredited knowledge and application-based continuing education. This is not an ACPE Certificate Program. Upon successful completion of the activities, the learner will be able to download an ASHP Professional Certificate.